Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Association of Cyclin D1 Variants with Head and Neck Cancer Susceptibility: Evidence from a Meta-analysis

  • Lin, Hai (Department of Otorhinolaryngology, Eye and ENT Hospital of Fudan University) ;
  • Fang, Lian (Department of Otorhinolaryngology, Eye and ENT Hospital of Fudan University) ;
  • Lin, Dong (Department of Biology and Chemical Engineering, Fuqing Branch of Fujian Normal University)
  • Published : 2014.07.30
Download PDF
⟨ Previous Next ⟩

Abstract

Whether cyclin D1 (CCND1) gene variants increase susceptibility to head and neck cancer (HNC) is undetermined. Therefore, we performed the present meta-analysis to systematically assess any possible association between CCND1 variants (G870A and G1722C) and HNC risk. Seventeen studies for CCND1 G870A and three studies for CCND1 G1722C were included. Overall, CCND1 polymorphisms (G870A and G1722C) had no association with increased HNC risk (p>0.05). In the subgroup analysis by smoking status, significantly increased HNC risk was found among smokers under allele contrast, homozygous comparison and recessive models (p<0.05), smoking carriers of A allele and AA genotype appearing at elevated risk. In conclusion, while there was overall a lack of any association between CCND1 polymorphisms (G870A and G1722C) and HNC risk, smokers carrying the A allele and AA genotype of the CCND1 G870A polymorphism may be susceptible to HNC development.

Keywords

References

  1. Abusail MS, Dirweesh AM, Salih RA, Gadelkarim AH (2013). Expression of EGFR and p53 in head and neck tumors among Sudanese patients. Asian Pac J Cancer Prev, 14, 6415-8. https://doi.org/10.7314/APJCP.2013.14.11.6415
  2. Catarino RJ, Breda E, Coelho V, et al (2006). Association of the A870G cyclin D1 gene polymorphism with genetic susceptibility to nasopharyngeal carcinoma. Head Neck, 28, 603-8. https://doi.org/10.1002/hed.20377
  3. Cui J, Shen L, Wang Y (2012). Specific CCND1 G870A alleles associated with breast cancer susceptibility: a meta-analysisof 5,528 cases and 5,353 controls. Asian Pac J Cancer Prev, 13, 5023-5. https://doi.org/10.7314/APJCP.2012.13.10.5023
  4. Deng L, Zhao XR, Pan KF, et al (2002). Cyclin D1 polymorphism and the susceptibility to NPC using DHPLC. Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao, 34, 16-20.
  5. Gomes CC, Drummond SN, Guimaraes AL, et al (2008). P21/ WAF1 and cyclin D1 variants and oral squamous cellcarcinoma. J Oral Pathol Med, 37, 151-6.
  6. Holley SL, Matthias C, Jahnke V, et al (2005). Association of cyclin D1 polymorphism with increased susceptibility to oral squamous cell carcinoma. Oral Oncol, 41, 156-60. https://doi.org/10.1016/j.oraloncology.2004.08.005
  7. Hopkins J, Cescon DW, Tse D, et al (2008). Genetic polymorphisms and head and neck cancer outcomes: areview. Cancer Epidemiol Biomarkers Prev, 17, 490-9. https://doi.org/10.1158/1055-9965.EPI-07-2714
  8. Huang M, Spitz MR, Gu J, et al (2006). Cyclin D1 gene polymorphism as a risk factor for oral premalignant lesions. Carcinogenesis, 27, 2034-7. https://doi.org/10.1093/carcin/bgl048
  9. Jelonek K, Gdowicz-Klosok A, Pietrowska M, et al (2010). Association between single-nucleotide polymorphisms of selected genes involved in the response to DNA damage andrisk of colon, head and neck, and breast cancers in a Polishpopulation. J Appl Genet, 51, 343-52. https://doi.org/10.1007/BF03208865
  10. Jemal A, Siegel R, Xu J,Ward E (2010). Cancer statistics, 2010. CA Cancer J Clin, 60, 277-300. https://doi.org/10.3322/caac.20073
  11. Li Y, Zhang S, Geng JX,Yu Y (2012). Effects of the cyclin D1 polymorphism on lung cancer risk, a meta-analysis. Asian Pac J Cancer Prev, 13, 2325-8. https://doi.org/10.7314/APJCP.2012.13.5.2325
  12. Lin HH, Ke HL, Hsiao KH, et al (2011). CCND1 1722 polymorphism and potential relevance to upper tracturothelial cancer. Anticancer Res, 31, 1043-7.
  13. Marsit CJ, Black CC, Posner MR, Kelsey KT (2008). Agenotype-phenotype examination of cyclin D1 on risk and outcome of squamous cell carcinoma of the head and neck. Clin. Cancer Res, 14, 2371-7.
  14. Matthias C, Branigan K, Jahnke V, et al (1998). Polymorphism within the cyclin D1 gene is associated with prognosis in patients with squamous cell carcinoma of the head and neck. Clin. Cancer Res, 4, 2411-8.
  15. Mishra A,Meherotra R (2014). Head and neck cancer: global burden and regional trends in India. Asian Pac J Cancer Prev, 15, 537-50. https://doi.org/10.7314/APJCP.2014.15.2.537
  16. Monteiro E, Varzim G, Pires AM, Teixeira M, Lopes C (2004). Cyclin D1 A870G polymorphism and amplification inlaryngeal squamous cell carcinoma: implications of tumor localization and tobacco exposure. Cancer Detect Prev, 28, 237-43. https://doi.org/10.1016/j.cdp.2004.04.005
  17. Nishimoto IN, Pinheiro NA, Rogatto SR, et al (2004). Cyclin D1 gene polymorphism as a risk factor for squamouscell carcinoma of the upper aerodigestive system in non-alcoholics. Oral Oncol, 40, 604-10. https://doi.org/10.1016/j.oraloncology.2003.12.009
  18. Niu YM, Shen M, Li H, et al (2012). No association between MTHFR A1298C gene polymorphism and head and neck cancer risk: a meta-analysis based on 9,952 subjects. Asian Pac J Cancer Prev, 13, 3943-7. https://doi.org/10.7314/APJCP.2012.13.8.3943
  19. Qin LY, Zhao LG, Chen X, et al (2014). The CCND1 G870 Agene polymorphism and brain tumor risk: a meta-analysis.Asian Pac J Cancer Prev, 15, 3607-12. https://doi.org/10.7314/APJCP.2014.15.8.3607
  20. Rydzanicz M, Golusinski P, Mielcarek-Kuchta D, Golusinski W, Szyfter K (2006). Cyclin D1 gene (CCND1) polymorphism and the risk of squamous cell carcinoma of the larynx. Eur Arch Otorhinolaryngol, 263, 43-8. https://doi.org/10.1007/s00405-005-0957-7
  21. Sabir M, Baig RM, Mahjabeen I, Kayani MA (2013). Significance of cyclin D1 polymorphisms in patients with head and neck cancer. Int J Biol Markers, 28, 49-55. https://doi.org/10.5301/JBM.2012.9768
  22. Sathyan KM, Nalinakumari KR, Abraham T, Kannan S (2006). Influence of single nucleotide polymorphisms in H-Ras and cyclin D1 genes on oral cancer susceptibility. Oral Oncol, 42, 607-13. https://doi.org/10.1016/j.oraloncology.2005.10.019
  23. Shih LC, Tsai CW, Tsai MH, et al (2012). Association of cyclin D1 genotypes with nasopharyngeal carcinoma risk. Anticancer Res, 32, 1093-8.
  24. Sui J, Gao W, Li XJ, et al (2009). Cyclin D1 gene G870 Apolymorphism and susceptibility to nasopharyngealcarcinoma. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, 44, 227-31.
  25. Tang C, Wang Z, Yu J, et al (2011). CCND1 G870A polymorphismand risk for head and neck cancer: a meta-analysis. Med Oncol, 28, 1319-24. https://doi.org/10.1007/s12032-010-9547-7
  26. Tsai MH, Tsai CW, Tsou YA, et al (2011). Significant associationof cyclin D1 single nucleotide polymorphisms with oralcancer in taiwan. Anticancer Res, 31, 227-31.
  27. Wong YK, Lin SC, Chang CS, et al (2003). Cyclin D1 genotype in areca-associated oral squamous cell carcinoma. J Oral Pathol Med, 32, 265-70. https://doi.org/10.1034/j.1600-0714.2003.00131.x
  28. Ye Y, Lippman SM, Lee JJ, et al (2008). Genetic variations in cell-cycle pathway and the risk of oral premalignant lesions. Cancer, 113, 2488-95. https://doi.org/10.1002/cncr.23854
  29. Zeybek U, Yaylim I, Ozkan NE, et al (2013). Cyclin D1 gene G870A variants and primary brain tumors. Asian Pac J Cancer Prev, 14, 4101-6. https://doi.org/10.7314/APJCP.2013.14.7.4101
  30. Zheng Y, Shen H, Sturgis EM, et al (2001). Cyclin D1 polymorphism and risk for squamous cell carcinoma ofthe head and neck: a case-control study. Carcinogenesis, 22, 1195-9. https://doi.org/10.1093/carcin/22.8.1195
  31. Zhuo W, Zhang L, Wang Y, Zhu B, Chen Z (2012). Cyclin D1 G870A polymorphism is a risk factor for esophageal cancer among Asians. Cancer Invest, 30, 630-6. https://doi.org/10.3109/07357907.2012.726385

Cited by

  1. Hypermethylation of Promoter Region of LATS1 - a CDK Interacting Protein in Oral Squamous Cell Carcinomas - a Pilot Study in India vol.16, pp.4, 2015, https://doi.org/10.7314/APJCP.2015.16.4.1599
  2. G870A (rs9344) polymorphism and cancer risk in Indian population: meta-analysis and trial sequential analysis vol.38, pp.6, 2018, https://doi.org/10.1042/BSR20180694